Close

Oppenheimer Downgrades Questcor Pharmaceuticals (QCOR) to Perform after Probe

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. TSLA
2. META
3. ENPH
4. TXN
5. BA
6. SPOT
7. IBM
8. V
9. HCP
10. CMG


Go back to Oppenheimer Downgrades Questcor Pharmaceuticals (QCOR) to Perform after Probe

Piper Jaffray Downgrades Questcor Pharmaceuticals (QCOR) to Neutral

September 24, 2012 9:43 AM EDT

Piper Jaffray downgraded Questcor Pharmaceuticals (NASDAQ: QCOR) from Overweight to Neutral following a U.S. probe into marketing practices. The firm's price target was cut from $67 to $43.

For an analyst ratings summary and ratings history on Questcor Pharmaceuticals... More

Questcor (QCOR) Slammed on U.S. Marketing Probe, Ratings Downgrade on Acthar Risk

September 24, 2012 7:59 AM EDT

Shares of Questcor Pharmacueticals, Inc. (NASDAQ: QCOR) are getting slammed in early trading Monday, down over 25 percent in pre-market action. The drop is the result of Questcor... More

U.S. Commences Probe into Questcor (QCOR) Over Marketing Practices

September 24, 2012 6:25 AM EDT

On September 21, 2012, Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) became aware of a U.S. government investigation involving the Companys promotional practices.

The Company intends to cooperate with the government in its investigation. Company representatives will not be able to provide any additional... More